General Information of the Compound
Compound ID |
CP0970067
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-4'-((4-(12-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yloxy)dodecyl)piperazin-1-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methylbiphenyl-3-carboxamide
Show/Hide
|
||||||||||||||||||
Formula |
C59H77N7O8
|
||||||||||||||||||
Molecular Weight |
1012.306
|
||||||||||||||||||
Canonical SMILES |
CCN(c1cc(-c2ccc(CN3CCN(CCCCCCCCCCCCOc4cccc5c4C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)cc(C(=O)NCc2c(C)cc(C)[nH]c2=O)c1C)C1CCOCC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C59H77N7O8/c1-5-65(46-25-33-73-34-26-46)51-37-45(36-48(42(51)4)55(68)60-38-49-40(2)35-41(3)61-56(49)69)44-21-19-43(20-22-44)39-64-30-28-63(29-31-64)27-14-12-10-8-6-7-9-11-13-15-32-74-52-18-16-17-47-54(52)59(72)66(58(47)71)50-23-24-53(67)62-57(50)70/h16-22,35-37,46,50H,5-15,23-34,38-39H2,1-4H3,(H,60,68)(H,61,69)(H,62,67,70)
Show/Hide
|
||||||||||||||||||
InChIKey |
YVJALPMAXFAUEB-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound